Radiopharm Theranostics Limited Sponsored ADR had a revenue of ― in the quarter ending ―, with ―. This bring the company's revenue in the last twelve months to ―, Decreased ―. In the fiscal year ending Dec 31, 2024, Radiopharm Theranostics Limited Sponsored ADR had annual revenue of 3.63M with 1114.27% growth.